|
|
|
Thu 4 Jun 2026
Close: 18600c 
Day's move: -109c (-0.58%)
Volume: 798 527
Trades: 2 829
|
|
|
|
Remgro - Mediclinic year end results
Remgro released a voluntary statement containing a summary of Mediclinic’s financial results for the year ended 31 March 2026. Mediclinic Holdings Ltd. reported a strong operational performance for the year ended 31 March 2026, despite challenging market conditions. Adjusted revenue increased by 11% to USD5.36 billion, driven by volume growth and favourable mix changes. Adjusted EBITDA rose by 14% to USD842 million, with an EBITDA margin of 15.7%. Adjusted earnings grew by 45% to USD345 million. The Group’s net debt remained stable at USD2.27 billion, and cash conversion was 106%. A proposed restructuring involves Remgro acquiring full ownership of Mediclinic Southern Africa for USD950 million, and MSC’s IHL acquiring Hirslanden for the same amount, leading to the classification of these divisions as discontinued operations. Impairment charges of USD555 million related to the Hirslanden division were recognised.
|
|
Click here for original article
|
| |
Remgro - disposal of FirstRand Ltd. shares
Remgro has disposed of its remaining 39 603 406 FirstRand shares through further on-market transactions, for an aggregate cash consideration of R3.59 million.
|
|
Click here for original article
|
| |
Remgro Ltd. - Dealings in securities by an executi
A director has dealt in shares of the company.
|
|
Click here for original article
|
| |
| |
| Click here for full news archive for this company |
|
| Closing price data source: JSE Ltd. All other statistics calculated by ProfileData. |
| |
|
|
